Skip to content
Home/Companies/Biotech/PepGen
PE

PepGen

Biotech·United States·Active·8yr hold

PepGen is a biotech company, headquartered in United States.

Entry
2018
Hold
8yr
Status
Active
Est. EV
–

Who owns PepGen?

PepGen is currently owned by Oxford Science Enterprises through Oxford Science Enterprises Balance Sheet (2015 vintage), since 2018.

Hand-verified · updated 2026-06-11

Oxford Science Enterprises
Investor
Oxford Science Enterprises
Oxford Science Enterprises Balance Sheet · 2015 · Balance Sheet

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Oxford Science Enterprises Balance Sheet

Other portfolio companies in the same fund.

Dark Blue Therapeutics
Exited 2026
BiotechUK· 2020
to
MiroBio
Exited 2022
BiotechUK· 2019
to
Oxford Ionics
Exited 2025
Deep TechUK· 2019
to
Latent Logic
Exited 2019
AI/MLUK· 2017
to
Oxford Semantic Technologies
Exited 2024
AI/MLUK· 2017
to
Brill Power
Exited 2025
EnergyUK· 2016
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings